ALAFI Capital Co. LLC, 10% Owner at Intra-Cellular Therapies, Inc. (ITCI), bought 34,000 shares at $14.50 ($493K) on 2016-11-14, disclosed to the SEC on 2016-11-17.
Open-market purchase of $493k ITCI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ITCI | BUY | 2014-12-03 | $21K | — | Filing → |
| ITCI | BUY | 2014-11-28 | $516K | — | Filing → |
| ITCI | BUY | 2014-11-21 | $15K | — | Filing → |